Dila Sayman
Research Subjects
Research Interests
Dila Sayman has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Burak Yulug
Department of Neurology, Alanya Alaaddin Keykubat University, Türkiye
3 shared publications - Ece Özdemir Öktem
ALANYA ALAADDİN KEYKUBAT ÜNİVERSİTESİ, TIP FAKÜLTES
3 shared publications - Ahmet Özşimşek
Department of Neurology, Alanya Alaaddin Keykubat Üniversitesi, 07400 Alanya, Türkiye
2 shared publications - Umutcan Duran2 shared publications
- Şeyda Çankaya
Alanya Alaaddin Keykubat Üniversitesi
2 shared publications - Ramazan Karaca1 shared publication
Latest Publications
- Open Access
- 29 October 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (4) , 78-80
Third cranial nerve palsy with confirmed HHV-6 positivity
We present a rare case of a 38-year-old man diagnosed with third cranial nerve paralysis, where no abnormalities were detected on MRI. Human Herpes Virus-6 (HHV-6) infection affecting the central nervous system and associated with cranial nerve paralysis is an unusual occurrence. This report underscores the importance of considering HHV-6 as a differential diagnosis in patients presenting with cranial nerve palsy and suggests the use of cerebrospinal fluid (CSF) HHV-6 polymerase chain reaction (PCR) testing for confirmation.
- 29 October 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (4) , 78-80
Open AccessThird cranial nerve palsy with confirmed HHV-6 positivity
We present a rare case of a 38-year-old man diagnosed with third cranial nerve paralysis, where no abnormalities were detected on MRI. Human Herpes Virus-6 (HHV-6) infection affecting the central nervous system and associated with cranial nerve paralysis is an unusual occurrence. This report underscores the importance of considering HHV-6 as a differential diagnosis in patients presenting with cranial nerve palsy and suggests the use of cerebrospinal fluid (CSF) HHV-6 polymerase chain reaction (PCR) testing for confirmation.
- Open Access
- 30 April 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (2) , 33-35
A rare case of hereditary ataxia: Gordon Holmes syndrome: a review of the literature
Gordon Holmes syndrome is an extremely rare, autosomal recessive condition with characteristic features of cerebellar progressive ataxia, cerebellar atrophy, and hypogonadotropic hypogonadism, which was first described in 1908 by the British neurologist of the same name. Two genes have to date been frequently associated with this syndrome, RNF216 and PNPLA61. A 23-year-old man presented with secondary sexual character deficiency and progressive difficulty in gait persisting for several years. He was eventually immobilized after seven years of ongoing symptoms and was definitively diagnosed with Gordon Holmes syndrome after genetic testing revealed RNF216 gene mutation.
- 30 April 2024
- Published by MediHealth Academy in Academic Journal of Neurology and Neurosurgery
- Vol. 1 (2) , 33-35
Open AccessA rare case of hereditary ataxia: Gordon Holmes syndrome: a review of the literature
Gordon Holmes syndrome is an extremely rare, autosomal recessive condition with characteristic features of cerebellar progressive ataxia, cerebellar atrophy, and hypogonadotropic hypogonadism, which was first described in 1908 by the British neurologist of the same name. Two genes have to date been frequently associated with this syndrome, RNF216 and PNPLA61. A 23-year-old man presented with secondary sexual character deficiency and progressive difficulty in gait persisting for several years. He was eventually immobilized after seven years of ongoing symptoms and was definitively diagnosed with Gordon Holmes syndrome after genetic testing revealed RNF216 gene mutation.
- Open Access
- 1 January 2022
- Published by Guven Plus Grup Danismanlik, A.S. in INTERNATIONAL REFEREED ACADEMIC JOURNAL OF SPORTS
- Vol. 1 (45) , 587-597
CEREBROVASCULAR DISEASES ASSOCIATED WITH COVID-19 INFECTION: A RETROSPECTIVE STUDY
Aim: The aim of this study was to investigate the frequency, clinical and radiologic characteristics of cerebrovascular diseases associated with Covid-19 infection. Method: In this retrospective, descriptive study, 514 patients who were treated for cerebrovascular disease in our hospital between September 2020 and May 2022 were reviewed. Among 514 stroke patients, 44 patients who had acute cerebrovascular diseases during Covid-19 infection were included in the study. Demographic characteristics, comorbid conditions, stroke risk factors, magnetic resonance imaging findings, and laboratory test results were recorded. Results: Of the 500 patients retrospectively analyzed, 44 (8.8%) had a cerebrovascular event during Covid-19 infection. The mean age of the 44 patients included in the study was 72.02±10.36 years. Ischemic stroke was observed in 37 (84.1%) patients, intracranial hemorrhage in 5 (11.4%) patients and transient ischemic attack (TIA) in 2 (4.5%) patients. Anterior system infarcts were observed in 28 (77.8%) and posterior system infarcts in 8 (22.2%) patients with ischemic stroke. The most common infarct was determined as cardioembolic in nature (36.1%). The most common risk factor observed in patients was atherosclerosis and the most preferred treatment modality was acetylsalicylic acid. Conclusion: Cerebrovascular diseases during Covid-19 infection are frequently ischemic strokes involving the anterior system. Close neurological follow-up is recommended during Covid-19 infection, especially in elderly patients with atherosclerotic risk factors.
- 1 January 2022
- Published by Guven Plus Grup Danismanlik, A.S. in INTERNATIONAL REFEREED ACADEMIC JOURNAL OF SPORTS
- Vol. 1 (45) , 587-597
Open AccessCEREBROVASCULAR DISEASES ASSOCIATED WITH COVID-19 INFECTION: A RETROSPECTIVE STUDY
Aim: The aim of this study was to investigate the frequency, clinical and radiologic characteristics of cerebrovascular diseases associated with Covid-19 infection. Method: In this retrospective, descriptive study, 514 patients who were treated for cerebrovascular disease in our hospital between September 2020 and May 2022 were reviewed. Among 514 stroke patients, 44 patients who had acute cerebrovascular diseases during Covid-19 infection were included in the study. Demographic characteristics, comorbid conditions, stroke risk factors, magnetic resonance imaging findings, and laboratory test results were recorded. Results: Of the 500 patients retrospectively analyzed, 44 (8.8%) had a cerebrovascular event during Covid-19 infection. The mean age of the 44 patients included in the study was 72.02±10.36 years. Ischemic stroke was observed in 37 (84.1%) patients, intracranial hemorrhage in 5 (11.4%) patients and transient ischemic attack (TIA) in 2 (4.5%) patients. Anterior system infarcts were observed in 28 (77.8%) and posterior system infarcts in 8 (22.2%) patients with ischemic stroke. The most common infarct was determined as cardioembolic in nature (36.1%). The most common risk factor observed in patients was atherosclerosis and the most preferred treatment modality was acetylsalicylic acid. Conclusion: Cerebrovascular diseases during Covid-19 infection are frequently ischemic strokes involving the anterior system. Close neurological follow-up is recommended during Covid-19 infection, especially in elderly patients with atherosclerotic risk factors.